Below are all of the latest news articles relating to
CXR Biosciences. Click on a news headline to read the full article:
| Success in ITI Life Sciences Research Programme leads to Extension and Further Funding of £2 million
Monday 25.2.08
30 novel transgenic models created to predict the effects of drug compounds in the human body....
The commercial partners for the programme are CXR Biosciences (Dundee, Scotland) and TaconicArtemis GmbH (Cologne, Germany).
|
| CXR Biosciences Raises Additional Growth Capital
Monday 25.2.08
CXR Biosciences Ltd, the innovator in new drug discovery and development technologies based in Dundee, UK, announced today the investment of £1.3M in the Company to support the global marketing of new technology platforms and services.
|
| CXR Biosciences announces New Dundee Research Collaboration
Wednesday 14.11.07
CXR Biosciences Ltd. today (14.11.2007) announces a major new £3 million collaborative research and development program aimed at predicting the safety risks of new drugs earlier in their development.
|
| CXR Biosciences and Taconic agree global marketing of HRN Model
Wednesday 28.3.07
In an agreement between CXR and Taconic, the HRN™ mouse will join Taconic’s portfolio of transgenic models that will be readily available in typical study quantities.......
|
| CXR Biosciences licenses HRN™ Mouse to Pfizer
Thursday 1.3.07
CXR Biosciences Ltd, an innovator in new preclinical drug development technologies based in Dundee, UK, today announced that it has signed a non-exclusive licence agreement with Pfizer Ltd to provide access to its HRN™ mouse technology. The HRN™ mouse is deficient in a protein which drives the hepatic cytochrome P450 system, a group of enzymes...
|
| CXR Biosciences and Artemis Pharmaceuticals granted licence to exploit novel transgenic models in drug discovery and development
Wednesday 22.11.06
ITI Life Sciences is pleased to announce that it has reached its first commercial milestone with the grant of a licence to CXR Biosciences and Artemis Pharmaceuticals to use new technology generated in its R&D programme to provide new predictive transgenic models for drug discovery and development......
|
| International Conference on Toxicological Hazard & Risk Assessment 2006 - a great success!
Wednesday 8.11.06
The inaugural 'International Conference on Toxicological Hazard & Risk Assessment' was held at the Hilton hotel in Dundee on 25-27th October 2006.....
|
| CXR Biosciences Wins Inaugural UK Bioentrepreneur Award
Thursday 3.8.06
CXR Biosciences Ltd, the innovator in new drug discovery and development technologies was selected as the first winner of the UK Innovation Enabling Biotechnology Award as part of the inaugural UK Bioentrepreneur Awards in London....
|
| CXR Biosciences Wins Tayside Business Award
Tuesday 18.4.06
CXR Biosciences Ltd, the innovator in new preclinical drug development technologies based in Dundee, UK, recently won the Tayside Business Award for Innovation & Creativity...
|
| ITI Life Sciences together with CXR Biosciences and Artemis Pharmaceuticals launch new £5.5 million R&D programme to develop new predictive safety models for early drug development
Friday 24.2.06
ITI Life Sciences (Dundee, Scotland), together with CXR Biosciences (Dundee) and Artemis Pharmaceuticals (Cologne, Germany), today announces the launch of a new £5.5 million R&D programme to develop new screening and safety models to more accurately predict...
|
CXR Biosciences is a partner in a ten million Euro R&D ..
